Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by august202013on Nov 29, 2022 11:58pm
240 Views
Post# 35138666

OPERATING EXP OF $1,757,249 AGST $952,127 SALES

OPERATING EXP OF $1,757,249 AGST $952,127 SALESHigh operating expenses $1,905,974 last year against higher sales figure $2,144,470 seems justified BUT current operating expenses questionable  ! 

Quite sure attributed to the process to secure the ISO CERTIFICATION and VYRA/CE MARK.

Seriously hope these high overhead costs will translate into some TURNOVER/SALES next reporting  otherwise will have to join STAGE ZERO &  gang  capital reduction syndrome 
<< Previous
Bullboard Posts
Next >>